Inactive Instrument

News ProMetic Life Sciences Inc. Toronto S.E.

Equities

CA74342Q1046

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Liminal BioSciences : Notice	23-09-26	PU
Liminal BioSciences Inc.(NasdaqCM:LMNL) dropped from NASDAQ Composite Index	23-09-26	CI
Structured Alpha LP, a fund managed by Thomvest Ventures, Inc. completed the acquisition of remaining 38.8% stake in Liminal BioSciences Inc. (DB:PJ2).	23-09-25	CI
Transcript : Liminal BioSciences Inc. - Shareholder/Analyst Call	23-09-15
Liminal BioSciences : Supplement to the Arrangement Circular – Special Meeting September 2023	23-09-12	PU
Liminal BioSciences : Notice of Special Meeting of Shareholders and Management Information Circular dated August 16, 2023 - Form 6-K	23-08-17	PU
Liminal BioSciences : Form of Proxy – Special Meeting September 2023	23-08-16	PU
Liminal BioSciences : Other	23-08-16	PU
Liminal BioSciences : Letter of Transmittal – Special Meeting September 2023	23-08-16	PU
Liminal BioSciences : Notice of Special Meeting - Special Meeting September 2023	23-08-16	PU
Liminal BioSciences : Arrangement Circular – Special Meeting September 2023	23-08-16	PU
LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP	23-08-16	AQ
Liminal BioSciences : Other	23-08-15	PU
Liminal BioSciences : Form of proxy - English	23-08-15	PU
Liminal BioSciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Liminal BioSciences : 52-109F2 - Certification of interim filings - CEO (E)	23-08-07	PU
Liminal BioSciences : 52-109F2 - Certification of interim filings - CFO (E)	23-08-07	PU
Liminal BioSciences : Annual MD&A - English	23-08-07	PU
Liminal BioSciences : Interim financial statements/report - English	23-08-07	PU
Liminal BioSciences : News release - English	23-08-07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ProMetic Life Sciences Inc. Toronto S.E.

Equities

CA74342Q1046

Summary

Filters